Molecular Discoveries Shed Light On Liver Cancer
Genomics improves our ability to target experimental liver cancer treatments.
|
Sunitinib May Slow Growth Of Liver Cancer
Treatment with sunitinib slows tumor growth and reduces the risk of metastasis in patients with hepatocellular carcinoma, an aggressive cancer of the liver.
|
Sunitinib May Slow Growth, Spread Of Liver Cancer
Treatment with sunitinib slows tumor growth and reduces the risk of metastasis in patients with hepatocellular carcinoma, an aggressive cancer of the liver.
|
FDA Approves Nexavar As First Drug Treatment for Liver Cancer
Nexavar becomes the first FDA-approved drug treatment therapy for patients suffering from liver cancer. Nexavar is made by Bayer Healthcare and the FDA liver cancer treatment node was announced today.
|
Progen Continues Clinical Program For PI-88 In Liver Cancer
Progen Pharmaceuticals awarded to PI-88 for the prevention of tumour recurrence following curative resection of primary liver cancer and in order to commence the Phase 3 program as rapidly as possible, the Company will no longer continue with the Special Protocol Assessment process.
|
Molecule Blocks Gene, Sheds Light On Liver Cancer
New research shows how a particular small molecule blocks the activity of a cancer-suppressing gene, allowing liver-cancer cells to grow and spread.
|
Uncooked fish linked with liver cancer in Asia
The link between eating uncooked fish and liver cancer in South East Asia.
|
In 'Spontaneous' Liver Cancer, Researcher Sees a Cure
Adding more good news to last week's announcement that Nexavar (sorafenib) may be the first effective treatment for advanced liver cancer, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have uncovered a new molecular mechanism that may "spontaneously" cause liver cancer.
|
Nexavar Significantly Extends Liver Cancer Patients' Overall Survival by 44 Percent
Bayer and Onyx Pharmaceuticals say Nexavar tablets significantly extended overall survival in primary liver cancer versus those taking placebo by 44 percent.
|
Blood DNA can be early predictor of liver cancer
This is the first study to examine potential biomarkers for early detection of liver cancer in high-risk populations.
|
Nexavar shown to significantly extend survival for patients with advanced liver cancer
Trial of Nexavar for liver cancer survival and treatment to be stopped early based on positive outcome.
|
Turning a cellular sentinel into a cancer killer
Researchers have developed two strategies to reactivate the p53 gene in mice, causing blood, bone and liver tumors to self destruct.
|
Novel radiation technique to treat liver cancer
When treating liver cancer Mayo doctors are using tiny glass bubbles filled with radioactive material to deliver high doses of tumor killing radiation directly to liver tumors.
|
Prognosis Of Liver Cancer
Higher levels of cells originating in bone marrow may be useful in prognosis of liver cancer.
|
Study Reveals Childhood Liver Cancer Risk
Despite liver cancer being extremely rare, with only around ten cases recorded annually in the UK, the finding is significant as the disease should be preventable once the gene fault is identified.
|
Anti-Inflammatory Drug Prevents Liver Cancer In At-Risk Liver Patients
Colchicine, an anti inflammatory drug most often used to treat gout, prevented liver cancer in patients with hepatitis virus related end stage liver disease.
|
A Unique Pattern of Gene Activity that Can Predict Liver Cancer Spread
A unique pattern of activity for genes in cells located in the tissue surrounding a liver tumor can accurately predict whether the cancer will spread to other parts of the liver or to other parts of the body.
|
Cycles of Cell Death, Proliferation Key To Liver Cancer
liver cancer is likely caused by cycles of liver cell death and renewal.
|
Omega-3 Fatty Acids Inhibit Growth of Liver Cancer Cells
Omega 3 fatty acids may be an effective therapy for both the treatment and prevention of human liver cancers.
|
Liver Cancer Linked to Cellular Repair Pathway
The unchecked activity of a cell signaling pathway crucial in embryonic development and the liver's response to injury leads to liver cancer.
|
Cirrhosis Patients With Liver Nodules Have Greatly Increased Risk of Cancer
Cirrhosis patients with small "nodules" in their livers are 25 times more likely to develop cancer than those without nodules.
|
New Compound May Protect Against Liver Cancer
The compound's effectiveness at very low doses suggests it may have similar cancer fighting properties in humans.
|
Precision Radiation Therapy Yields Rare Success for Liver Tumors
Shaped beam radiation therapy is a promising treatment for life threatening metastatic liver tumors.
|
Purdue, Vanderbilt Scientists Develop New Cancer Detection Technique
By custom modifying a device called a mass spectrometer a team has found that the wand-like sample probe can be used to identify liver cancers.
|
MRI Better Than FDG PET at Detecting Liver Tumors
Significantly more and smaller liver tumors can be detected by contrast enhanced MRI when compared to whole body FDG PET.
|
Unique Dual Treatment for Liver Cancer Packs Curative Punch
Liver cancer is often not diagnosed till advanced stages because the symptoms are difficult to recognize. Some signs of liver cancer are pain, jaundice and unexplained weight loss.
|
NCI Begins Validation Study of New Test to Detect Early-Stage Liver Cancer
It's the first study testing a marker for liver cancer, and the first Phase II EDRN supported study.
|
